人工肌腱和韧带市场规模、份额、成长分析、按植入类型、按应用、按最终用户、按地区 - 行业预测 2025-2032

2023 年全球人工肌腱和韧带市场规模价值 111 亿美元，预计将从 2024 年的 126.1 亿美元增长到 2032 年的 349.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 13.6%。

由于对微创手术的需求不断增加以及对运动伤害的认识不断提高，人工韧带市场预计将显着增长。人工韧带的设计主要考虑因素包括机械性能、材料选择以及临床试验的全面评估。尤其令人担忧的是运动相关伤害的发生率很高，2019 年英国报告的运动相关伤害发生率达 165,000 起，凸显了对有效解决方案的需求。合成材料的创新对于克服传统植入方法相关的併发症（例如断裂和膝盖不适）至关重要。产业相关人员和研发机构积极致力于研发能够与天然组织结合并促进癒合的先进合成植入物。纤维增强水凝胶等有前景的发展已经出现，增加了市场的成长潜力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

人工肌腱和韧带市场规模（以植入类型）

• 市场概况
• 硅胶棒植入
• 玛莱克斯网
• 碳纤维植入
• 其他的

人工肌腱和韧带市场规模（依应用）

• 市场概况
• 膝盖受伤
• 肩部受伤
• 足部和踝部损伤
• 脊髓损伤
• 髋关节损伤
• 其他的

人工肌腱和韧带市场规模（按最终用户划分）

• 市场概况
• 医院
• 专科门诊
• 门诊手术中心
• 其他的

人工肌腱和韧带市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Smith+Nephew（United Kingdom）
• Zimmer Biomet（United States）
• Xiros Ltd.（Neoligaments）（United Kingdom）
• Orthomed SAS（France）
• Shanghai PINE&POWER Biotech（China）
• Arthrex Inc.（United States）
• Corin Group（United Kingdom）
• Enovis Corporation（Mathys AG Bettlach）（Switzerland）
• Stryker Corporation（United States）
• GROUP FH ORTHO（France）
• FX Solutions（France）
• LARS（Corin Group）（France）
• Cousin Biotech（France）
• Mathys AG Bettlach（Switzerland）
• Ossur hf（Iceland）
• Integra LifeSciences Holdings Corporation（United States）
• Medtronic plc（Ireland）
• Orthonika, Inc.（United Kingdom）
• United Orthopedic Corporation（Taiwan）

结论和建议

Global Artificial Tendons And Ligaments Market size was valued at USD 11.1 billion in 2023 and is poised to grow from USD 12.61 billion in 2024 to USD 34.97 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

The artificial ligament market is poised for significant growth due to increasing demand for minimally invasive procedures and heightened awareness of sports injuries. Key design considerations for these products include mechanical performance, material selection, and thorough evaluation during clinical studies. A notable concern is the high incidence of sports-related injuries, with 165,000 cases reported in England in 2019, underscoring the need for effective solutions. Innovations in synthetic materials are critical to overcoming the complications associated with traditional graft methods, such as tendon rupture and knee discomfort. Industry players and research institutions are actively engaged in R&D to develop advanced synthetic grafts that can blend with natural tissues and promote healing. Promising developments, such as fiber-reinforced hydrogels, are emerging, reinforcing the market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Tendons And Ligaments market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Tendons And Ligaments Market Segmental Analysis

Global Artificial Tendons And Ligaments Market is segmented by Implant Type, Application, End User and region. Based on Implant Type, the market is segmented into Silastic-rod implant, Marlex mesh, Carbon-Fibre implant and Others. Based on Application, the market is segmented into Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Spine Injuries, Hip Injuries and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Tendons And Ligaments Market

A key factor driving the Global Artificial Tendons and Ligaments market is the surge in sports injuries, which primarily arise from accidents, improper techniques, inadequate warm-ups, stretching, and poor conditioning. Many athletes experience common injuries such as tennis elbow, ankle sprains, groin pulls, hamstring strains, and ACL tears. Especially in developed countries like the U.S. and the U.K., the rising incidence of these sports-related injuries is expected to significantly boost the demand for artificial tendons and ligaments. Moreover, the increasing acceptance of minimally invasive surgical techniques for tendon and ligament reconstruction is fostering market growth, as patients increasingly prefer less painful surgical options. Progress in knee replacement procedures further enhances clinical opportunities, indicating a promising trajectory for the market's expansion in the near future.

Restraints in the Global Artificial Tendons And Ligaments Market

The growth of the Global Artificial Tendons and Ligaments market is anticipated to be hindered by escalating research and development expenses during the forecast period. Furthermore, safety and regulatory challenges are likely to pose significant obstacles in the near future. Healthcare providers exhibit hesitance towards the adoption of artificial tendons and ligaments, primarily due to the prohibitive costs linked to the procedures and a lack of favorable reimbursement policies. Additionally, the clinical efficacy of these artificial implants is compromised by various risks, with synovial membrane inflammation standing out as a major concern among patients undergoing treatment.

Market Trends of the Global Artificial Tendons And Ligaments Market

The Global Artificial Tendons and Ligaments market exhibits a compelling trend toward the knee injury segment, projected to dominate market share due to rising sports participation rates, leading to a surge in knee injuries. This trend is further fueled by patient dissatisfaction with traditional surgical approaches using allografts, which can result in prolonged recovery and availability issues. Innovations in artificial ligaments provide significant advantages, including reduced recovery times, enhanced availability, and expedited surgical procedures compared to donor tendon grafts. As a result, healthcare professionals and patients are increasingly favoring these advanced solutions, solidifying the segment's leading position in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Artificial Tendons And Ligaments Market Size by Implant Type & CAGR (2025-2032)

• Market Overview
• Silastic-rod implant
• Marlex mesh
• Carbon-Fibre implant
• Others

Global Artificial Tendons And Ligaments Market Size by Application & CAGR (2025-2032)

• Market Overview
• Knee Injuries
• Shoulder Injuries
• Foot & Ankle Injuries
• Spine Injuries
• Hip Injuries
• Others

Global Artificial Tendons And Ligaments Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centres
• Others

Global Artificial Tendons And Ligaments Market Size & CAGR (2025-2032)

• North America (Implant Type, Application, End User)
  • US
  • Canada
• Europe (Implant Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Implant Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Implant Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Implant Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Smith+Nephew (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xiros Ltd. (Neoligaments) (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthomed S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai PINE&POWER Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corin Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enovis Corporation (Mathys AG Bettlach) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GROUP FH ORTHO (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FX Solutions (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LARS (Corin Group) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cousin Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mathys AG Bettlach (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ossur hf (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthonika, Inc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Orthopedic Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations